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1. Introduction
Botulinum neurotoxins (BoNTs) are some of the most lethal human bacterial toxins and the
causative agent of botulism (Arnon et al., 2001; Simpson, 2004). The usual routes of
intoxication for BoNTs are oral ingestion of clostridial spores or pre-formed toxin,
manifested as infant, foodborne and adult onset botulism. An increasingly common route of
intoxication is associated with intravenous drug use resulting in wound botulism. BoNTs
are also classified as Select Agents and have been used as agents of bioterrorism (Arnon et
al., 2001; Bigalke and Rummel, 2005). Potential methods for toxin exposure include
intentional contamination of the food and drink supply, or by aerosol spread, leading to
inhalational botulism.
Usually, an identification of botulism is made through clinical manifestations and diagnosis,
with subsequent confirmation by laboratory identification of clostridial spores or toxin in
foods, environmental or clinical samples (CDC, 1998; Lindström and Korkeala, 2006;
Solomon and Lilly, 2001). The speed of recovery from botulism increases with the timely
administration of antitoxin or medical interventions (Arnon et al., 2001; Simpson, 2004).
Thus, sensitive and rapid toxin detection and diagnostic methods are critical for improved
recovery time, as well as, facilitate the epidemiologic study of outbreaks.
Due to the potential for bioterrorism use, much effort and resources have been dedicated to
the development of detection methods, treatment, and prevention of botulism. A multitude
of assay formats have been developed over many years, with in some cases, reported
sensitivities at the attomolar level (Grate et al., 2010). Many assays were designed for use in
the validation of toxin production, for commercial purposes, or for high-throughput
screening methods to identify therapeutics that inhibit toxin function. These highly sensitive
methods usually detect highly purified BoNT samples and are used in research type
applications. Many such assays are not usable for the detection of BoNT contamination in
food or other complex samples. This chapter focuses on the diagnostic methods for toxin
detection and the challenges encountered while adapting analytical methods for the
detection of BoNTs in foods and other biological and environmental samples.
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The biology and mechanisms of action of BoNTs are described in a previous chapter in this
book, and readers should refer to the botulinum neurotoxins chapter by Webb, RoxasDuncan and Smith, for more background reading. This chapter will briefly describe the
properties of BoNTs as they relate to detection methods and will compare and contrast
currentlyused methods for food and biological sample analyses and methods in
development. For detailed analyses and descriptions of detection assays please also refer to
excellent reviews by (Grate et al., 2010; Lindström and Korkeala, 2006; Scarlatos et al., 2005;
Sharma and Whiting, 2005). We apologize to others not named here due to space
constraints.

2. Overview of botulinum neurotoxin structure and function as they relate to
the development of diagnostic tools
A single gram of BoNT released and subsequently inhaled can lead to the deaths of more
than one million people (Arnon et al., 2001; Hill et al., 2007). BoNTs are produced by the
ubiquitously distributed, gram-positive, strictly anaerobic, spore-forming bacteria
Clostridium botulinum, C. barati, C. butyricum and C. argentinense. To date, seven different
botulinum serotypes, indicated by letters A through G, have been identified. Serotypes A, B,
E, and F have been associated with human disease (Table I).
Type of botulism

Average number of
cases per year

Percent of total

BoNT Serotypes

Infant

85

66

A, B, E, F

Wound

24

19

A, B

Foodborne

19

15

A, B, E, F

Adult

0.4

0.3

A, B, F

Unknown

1.4

1

A, B, F

Table 1. Survey of U.S. human botulism cases from 2001-2009 as reported by the U.S.
Centers for Disease Control and Prevention (CSTE).
BoNT serotypes can differ from each other by 34-64% at the amino acid level (GarciaRodriguez et al., 2011; Hill et al., 2007; Jacobson et al., 2011; Smith et al., 2007; Smith et al.,
2005). Genetic variation within each serotype is sometimes significant. And 32 toxin
subtypes with amino acid level differences of 2.6-32% have been identified thus far, with
more likely to be identified in the future. Serotype and subtype diversity may impact
antibody and molecular-based assay designs.
BoNT is synthesized as an ~150 kDa protein, also called the holotoxin, that is subsequently
processed by a clostridial trypsin-like protease into two polypeptides linked by a single
disulfide bond; and are thus similar to other known bacterial A-B dimeric toxins (Oguma,
Fujinaga, and Inoue, 1995; Singh, 2000). The ~100 kDa fragment, known as the heavy chain
(HC), facilitates toxin binding to specific host cell receptors and later, translocation of the
toxin from vesicles into the cell cytosol. The ~50 kDa fragment, known as the light chain
(LC), contains the enzymatic domain. The LC fragment is often used for the development of
activity-based assays. HC and LC specific antibodies have been developed for toxin
neutralization and toxin detection immunoassays.
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BoNT holotoxin is secreted from bacteria in association with other non-toxic proteins, called
neurotoxin associated proteins or NAPs, forming large protein complexes of 500-900 kDa.
These large protein complexes are referred to as progenitor toxins or simply as BoNT
complex (Inoue et al., 1996). Complexed BoNTs are significantly more toxic in oral
intoxications (Cheng et al., 2008; Ohishi, Sugii, and Sakaguchi, 1977) than holotoxins. NAPs
are thought to protect the holotoxin from gastric digestion as well as help holotoxins cross
the intestinal barrier (Fujinaga et al., 2009; Niwa et al., 2007; Simpson et al., 2004). Toxin
complexes that survive the gastric challenge translocate across the epithelial cell barrier
(transcytosis) gaining access into the bloodstream, where the holotoxin is released. BoNT
complexes are the forms that will most likely be found in natural intoxication and
bioterrorism cases. Thus, the detection of toxin when associated with NAPs or the use of
NAPs as detection targets in foodborne intoxications is a consideration in the design of new
assays.
The target for BoNT holotoxin is the peripheral cholinergic nerve ending, resulting in flaccid
paralysis (Simpson, 2004). Specific receptors for the toxin HC of BoNTs have been identified;
BoNT/A binds to glycoprotein SV2; serotype F binds SV2 and gangliosides; and serotype G
binds synaptotagmin I and II. Toxin binding to nerve cells is followed by receptor-mediated
endocytosis and subsequent translocation of the LC (directed by the translocation domain of
the HC) into the cytoplasm. The LC of different serotypes targets different SNARE proteins.
BoNT serotypes A, C and E target SNAP-25, and serotypes B, D, F, and G target VAMP2,
while serotype C targets syntaxin (Hakami et al., 2010). Different SNARE targets of BoNTs
have been used to develop in vitro assays for toxin activity. Peptides with fluorescent labels
and quencher molecules have been designed and used in various forms of enzymatic
activity assays.

3. Challenges to the development of detection assays for botulinum
neurotoxins
The development of robust and sensitive detection assays for BoNTs requires consideration
of at least six factors explored in detail below.
3.1 Sensitivity
Assay sensitivity is not a simple criterion to define and is determined in part by the specific
application. For example, the human lethal dose (LD) for oral intoxication is estimated at 1
µg/kg or about 70 µg for a 70 kg adult (Arnon et al., 2001; Scarlatos et al., 2005). Assays
designed for evaluating food must detect at least this amount in a typical portion. Since
portions vary widely between individual foods, assay sensitivity requirements may vary
with specific matrixes. Foods that typically have large portion sizes would require assays
with lower detection limits. Furthermore the dose to cause illness but not death might be
lower. Our experience with BoNT exposure in rodents is that a level 10-fold lower than the
minimal lethal dose falls into this latter category. Thus, a dose level 10-fold lower than the
LD in humans, 7 µg, translates into an assay sensitivity of 70 ng/mL if a serving is typically
100 mL. A 10-fold threshold lowers the sensitivity to 7 ng/mL. In contrast, detection levels
for tests used in sera or other clinical matrices should be as sensitive as possible to account
for low toxin levels. For example, in oral mouse toxicity studies, only a small portion of the
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ingested BoNT actually survives the harsh conditions in the gut to reach the bloodstream
(Cheng and Henderson, 2011; Cheng et al., 2008). The lethal toxin intravenous dose varies
between 20-200 ng in an adult human with approximately 5 liters of blood (Arnon et al.,
2001). Taking into account natural degradation, and clearance of toxin in sera, the assay
sensitivity for diagnostic evaluation must be in the low to sub-pg/ml range.
3.2 Specificity
There are currently seven known serotypes of BoNTs, and 32 known subtypes. New
subtypes are expected to be identified in the future. Amino acid sequence differences can
vary as much as 70% among serotypes (Hill et al., 2007; Smith et al., 2005). This level of
genetic diversity and variation can prove challenging for both molecular and antibodybased diagnostic methods. False negative results could be obtained if a gene or protein
structure of the toxin differ from what established oligonucleotides/PCR primers or
antibodies can recognize. At the very least, assay performance needs to be established on as
many toxin sero- and subtypes as practical. Reagents generated for detection assays should
ideally recognize all known subtypes of each serotype.
3.3 Matrix effects
In almost all scenarios, BoNT samples to be tested would be found in a wide variety of
matrices of food, clinical (serum, sputum, feces, etc) or environmental samples (dust, soil,
water, etc). Yet, most assay methods are designed, tested and optimized in buffer conditions
and thus the sensitivity or application in complex matrices may be diminished. Complex
matrices may contain many challenging conditions such as high fat, high protein or salt
content, low or high pH; the presence of other active proteases could also interfere with
detection sensitivity, increase background signal, and give false positive or negative signals.
Methods to alleviate matrix interference range from simple sample dilution, pH rebalancing,
addition of protease inhibitors, to specific affinity binding steps prior to detection. Extensive
analysis of different matrices will be necessary to evaluate assay sensitivity and determine
the best methods to circumvent matrix effects on assay performance.
3.4 Activity
The potent toxicity associated with BoNTs is attributed to their enzymatic properties. The
differentiation of active versus inactive forms of the toxin is needed for proper risk
assessment and should be an important consideration in assay design. An active BoNT has
many roles, it must be able to bind host cell receptors, translocate across membranes and
finally reach the host cell cytosol and cleave its target protein. Few assays can measure all
aspects of toxin function. Immunoassays (IA) can generally detect both active and inactive
toxin and may give false positive results even when no active toxin is present. However,
positive results from IA requiring the presence of both HC and LC are predictive of active
toxin (Stanker et al, 2008). Assays measuring endopeptidase activities of BoNTs are available
but are not as sensitive and amenable to use in complex matrices. Genomic methods, while
sensitive, detect the presence of toxin genes but not that of toxin. Depending on the
diagnostic needs, a combination of methods may have to be used to get a full activity profile
of the toxin.
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3.5 Ease of use
For the widest application of an assay, it must be user-friendly and allow for a timely
diagnosis. Furthermore, assays need to be validated in multiple laboratories, use equipment
or tools that are readily available, and require minimal training to execute. Ideally, the assay
should also be field deployable.
3.6 Cost
The cost of an assay in terms of reagent or equipment availability can be an important factor
on how widely an assay is used and deployed.

4. Current diagnostic methods of toxin detection
The current “gold standard” for detection of BoNTs is the mouse bioassay. Despite many
attempts and much research to replace the use of animals, it is still the best assay to model
all aspects of BoNT intoxication: binding, translocation and enzymatic activity (Grate et al.,
2010). In attempts to replace the mouse bioassay and improve assay time and sensitivity,
both in vitro and in vivo systems have been developed for the detection of BoNTs. The
development of a robust detection assay for BoNT requires that the assay meet as many of
the six challenges mentioned above as possible. This section of the chapter will mainly focus
on assays that can be used in food and biological samples for the detection of BoNTs.
4.1 Mouse bioassays
The mouse bioassay is still one of the most sensitive and robust methods to detect BoNTs
(Schantz and Kautter, 1978; Solomon and Lilly, 2001). The mouse bioassay measures BoNT
in minimal lethal dose (MLD) units, which is the lowest dose at which all tested mice die.
Mice are usually injected intraperitoneally with 0.5 ml of BoNT sample in a dilution series,
and then monitored over several days for signs of intoxication and death (CDC, 1998;
CFSAN, 2001). Signs of intoxication include: ruffled fur, wasp-waist (Figure 1), laboredbreathing, paralysis and death. Signs of intoxication can appear from a few hours postinjection to a few days depending on the dose and type of BoNT. When enough sample is
available, the identity of the unknown BoNT can simultaneously be tested by the addition of
neutralizing antibodies against each of the serotypes (A-G). The serotype is identified by the
antibody that protects their respective mice from death. The mouse bioassay sensitivity is in
the range of 20-30 pg for BoNT/A and 10-20 pg/ml for BoNT/B (Ferreira et al., 2004;
Wictome et al., 1999).
While the mouse bioassay has high sensitivity, can detect different serotypes and subtypes,
measures different aspects of active toxin, and is amenable to use in different matrices, it has
many drawbacks. These include: long assay times, requires specialized animal facilities,
trained staff, and the use of animals (with death used as an endpoint). There is also
substantial variation of results observed among different research laboratories.
Alternative refined animal assays that do not use death as an endpoint such as the mouse
phrenic nerve hemi-diaphragm assay have been evaluated (Rasetti-Escargueil et al., 2009).
Although they may be sensitive and faster than the use of whole animals, these assays
require use of sophisticated equipment and training, and are not amenable for use with
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large samplings of complex matrices (Grate et al., 2010). A recently developed in vivo assay
using the toe-spread reflex model was tested for the detection of BoNT in buffer, serum and
milk samples (Wilder-Kofie et al., 2011). This new assay can provide results more quickly
than standard mouse bioassays. The robustness of this assay and how easily staff can be
trained to perform this assay have yet to be determined.

Fig. 1. Mouse bioassay. Mice were intraperitoneally treated with BoNT/A (right mouse) or
phosphate buffered saline (left mouse). The intoxicated mouse shows a typical wasp-waist
phenotype.
4.2 Nucleic acid based methods of detecting C. botulinum in food matrices and other
biological samples
4.2.1 Polymerase chain reaction
The use of the polymerase chain reaction (PCR) to identify the presence of C. botulinum
DNA was originally used to detect the presence of bacterial spores. The method could detect
the presence of as few as 102 spores per reaction mixture for serotypes A, E and F and only
10 spores per reaction mixture for BoNT/B. To enhance sensitivity, Lindström and
colleagues developed an enrichment method that could detect as few as 10-2 spores/gram of
sample for serotypes A, B and F and 10-1 spores/gram of sample for BoNT/E (Lindstrӧm et
al., 2001). However, one critical drawback of this method is that enrichment often requires 5
days. Furthermore, the applicability of the assay for detection of food contamination was
diminished by the observation that beef could interfere with the sensitivity of the assay.
Also, if contamination were to occur with the actual toxin, and not cells, this traditional PCR
method would not be useful.
4.2.2 Multiplex polymerase chain reaction
It is highly desirable to analyze unknowns for multiple targets, such as different pathogens
and/or associated gene products of those pathogens. This approach, known as Multiplex
technology, is conceptually simple for PCR based assays. Different sets of PCR primers, each

www.intechopen.com

Current Methods for Detecting
the Presence of Botulinum Neurotoxins in Food and Other Biological Samples

7

one highly specific for a gene of interest can be easily generated, allowing for the
amplification of multiple targets in one reaction tube. One such multiplex method was able
to discriminate among BoNT serotypes A, B, E, and F, corroborating mouse bioassay results
(De Medici et al., 2009). Furthermore, Peck and colleagues developed a culture enrichment
methods that when coupled with multiplex PCR, can identify strains of C. botulinum that are
non-proteolytic (BoNT serotypes B, E, and F) (Peck et al., 2010). Importantly, this method
was robust and reasonably rapid for use with food samples contaminated with C. botulinum.
Recently, Fach and colleagues have adapted the use of the GeneDisc Cycler (GeneSystems
PCR Technology) to amplify C. botulinum genes encoding BoNT serotypes A, B, E, and F on
different microchambers (Fach et al., 2011). This technology allows the simultaneous
amplification of multiple targets along with a number of different internal controls. A
number of different toxin-producing clostridia and non-toxin producing bacteria that were
isolated from different food, clinical, and environmental samples and results were compared
with those obtained from the mouse bioassay. Notably, all of the botulinum genes were
detected correctly and no cross-reactivity was observed with either non-toxin producing
bacteria or with C. botulinum serotypes C, D, and G. Four European laboratories evaluated
this technology, examining 77 toxin producing clostridia as well as 10 food and clinical
samples. In all cases, this GeneDisc Cycler was specific and reliable for identifying C.
botulinum serotypes A, B, E, and F; and was also useful for screening naturally contaminated
food and fecal samples.
4.2.3 Real-time polymerase chain reaction
Real-time or quantitative PCR is useful in studies of gene expression; specifically differential
expression of genes under different environmental conditions or for comparative studies
among different organisms. For detection of clostridia, real-time PCR methods that examine
expression of the NTNH (non-toxic, non-hemagglutinin) genes have been developed, as
well as methods to study toxin gene expression in C. botulinum serotypes A, B, E, and F
(Fach et al., 2009). In that study, twenty-nine different strains of toxin-producing C.
botulinum were screened, and compared with expression profiles from non-toxin producing
clostridia as controls. This assay has a sensitivity of 100-fg/1000 fg total DNA in the PCR
tube (equivalent to approximately 25-250 genomes). Converting this DNA concentration to
its equivalent in cells/ml, suggested a detection limit of approximately 103 to 104 cells/mL.
Following a 48-hour enrichment under anaerobic conditions, these investigators reported
the detection of C. botulinum serotype A in a naturally contaminated sample of foie gras
suspected in a botulism outbreak. Recently, pentaplex methods have been developed to
simultaneous identify and discriminate among larger numbers of different serotypes using a
wider array of different genes (Kirchner et al., 2010). This technology should prove to be
efficient and cost-effective.
4.2.4 DNA microarrays
Microarray technology for toxin identification of contaminated food has not been widely used.
This may be due to the challenge in isolating high-quality RNA samples from clostridia in
food matrices. A recent oligonucleotide microarray with 62 different sequences based on
known strain variable regions in the genome of C. botulinum strain ATCC 3502 was
constructed and used to differentiate different C. botulinum type A strains (Raphael et al.,
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2010). Regions corresponding to BoNT genes of various serotypes, and other markers
components, and other markers were observed. Further development of microarray based
assay approaches may provide a means to rapidly identify toxin-producing strains.
4.3 Antibodies as detection tools for BoNT contamination in food
High-affinity monoclonal antibodies (mAbs) that specifically bind individual or multiple
BoNT serotypes (and subtypes) have been generated using either mouse hybridoma
technology or yeast affinity maturation methods (Grate et al., 2010). These antibodies have
been used extensively in traditional ELISA, bead-based, immuno-PCR, microarray assays or
in sample preparation before use in a detection assay. Several such assays used in food and
biological matrices are highlighted below.
4.3.1 ELISA and ELISA-based methods of detection
ELISA is a widely used detection assay format that uses anti-BoNT capture and detector
antibodies usually in a sandwich type format. The read-out for the assay can be colorimetric,
luminescence or other formats. Most older generation BoNT immunoassays are about 10
times less sensitive than the mouse bioassay (Ferreira et al., 2004; Scarlatos et al., 2005;
Sharma and Whiting, 2005). Although not as sensitive, ELISA based methods are relatively
fast, inexpensive and simple. They are also less subject to matrix effects. Sharma and
colleagues designed an amplified enzyme-linked immunosorbent assay (ELISA) for
detecting toxins in food matrices (Sharma et al., 2006). Specifically, toxins for serotypes A, B,
E, and F could be detected in liquids, solid, and semisolid food. Assay performance in a
range of foods include broccoli, orange juice, bottled water, cola soft drinks, vanilla extract,
oregano, potato salad, apple juice, meats, and dairy items were evaluated. Assay sensitivity
varied for each botulinum complex serotype, and were reported as 60 pg/ml for BoNT/A,
176 pg/ml for BoNT/B, 163 pg/ml for BoNT/E, and 117 pg/ml for BoNT/F. The tests
readily detected 2 ng/ml of serotypes A, B, E, and F in a variety of the foods tested.
Recently, traditional format sandwich ELISA assays using highly sensitive mAbs against
BoNT/A and BoNT/B have detected as low as 5 pg/mL and 25 pg/mL BoNT/A, in buffer
and in a milk matrix, respectively (Stanker et al., 2008); and 100 fg and 39 pg/ml of BoNT/B
in the buffer and milk matrix, respectively (Scotcher, Cheng, and Stanker, 2010). These
mAbs were also used in electrochemiluminescence ELISA type assays using a Meso Scale
Discovery (MSD) instrument. Detection sensitivities for BoNT/A using the MSD instrument
were similar to traditional ELISAs in the buffer system but offered marked improvement in
detection limits and reduction in backgrounds in liquid food matrices (Cheng and Stanker,
unpublished results). The higher sensitivity and less time required for these new ELISA
assays make them great alternatives or complements for the mouse bioassay.
4.3.2 Multiplex antibody-based detection systems
The multiplex technology has been applied to the development of methods to analyze
multiple epitopes on a single antigen or multiple targets in a single sample. This approach
uses multiple mAbs as well as polyclonal antibodies to reduce false-positive and falsenegative results. The Luminex xMAP technology utilizes microsphere beads conjugated
with antibodies. The antibody-bead complexes detect multiple epitopes in single sample; for
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instance, this technology was used to detect abrin, ricin, botulinum toxins, and
staphylococcal enterotoxins in spiked food samples (Garber, Venkateswaran, and O'Brien,
2010). The study used paramagnetic beads instead of non-magnetic polystyrene beads to
help in the analysis of food matrices, such as chipotle mustard, which contain large amounts
of particulate matter.
4.3.3 Affinity immunochromatography column-based methods
Accurate and sensitive detection of contaminated food and other biological samples in the
field is critical. To this end, Brunt and colleagues (Brunt, Webb, and Peck, 2010) have
developed a number of rapid affinity immunochromatography column (AICC) assays for
the detection of BoNT serotypes A, B, E, and F in food matrices. These authors reported a
detection limit for BoNT/A of 0.5 ng, two fold more sensitive than earlier reported lateral
flow methods. For serotypes B, E, and F, the minimum detection limit ranged from 5 ng to
50 ng. Although not as sensitive as ELISA or mouse bioassays, immunochromatographic
methods generally are rapid assays, requiring only 15 to 30 minutes to complete, do not
require enrichment steps, making them highly amenable to use in the field.
4.3.4 Lateral flow technology
The application of lateral flow methods for detecting toxins has led to the development of a
number of kits for sensitive and rapid testing. The principle here is that capture antibodies
are printed on nitrocellulose membranes. Detection antibodies are labeled with materials
that can be visualized (eg., colloidal gold, or colored latex beads) The sample is added to a
reagent pad containing labelled detection antibodies that bind toxin, wick across the
membrane where toxin is retained, thus concentrating the labelled detection antibody. A
positive reaction leads to a colorimetric change that is usually detected as a line. These
assays are generally qualitative, and determine the presence or absence of toxin. Sharma and
coworkers tested different commercial lateral flow devices (such as the Bot-Tox-BTA kit) for
their capacities to detect toxin in food samples (Sharma et al., 2005). They were able to detect
as little as 10 ng/ml of BoNT serotypes A and B and 20 ng/ml of BoNT/E in a variety of
liquids such as milk products, soft drinks, and fruit juices. Results by Stanker (unpublished)
show sensitivity of 0.5 and 1 ng/ml for BoNT/A in buffer and milk, respectively, in lateral
flow devices using sensitive mAbs described in the ELISA section above (Stanker et al.,
2008). Although simple lateral flow tests have poorer sensitivities compared to other
methods, they produced rapid results, require no additional reagents or equipment, are
easily interpreted, and have many applications. They can be useful for the quick screening
of samples where the presence of BoNT may be more abundant.
4.3.5 Immuno-polymerase chain reaction (I-PCR)
An innovative approach for toxin detection combines antibodies with the amplification
power of PCR in an assay called immuno-PCR (I-PCR). Here, instead of a secondary
antibody conjugated to the detection enzyme, template DNA is conjugated to the
antibody; and upon binding of antigen by the antibody, an indirect test for the presence of
the BoNT is carried out using PCR. Chao et al. described a sensitive I-PCR method
(femtogram amounts, 10-15 grams) for detection of BoNT/A. These investigators also
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compared standard ELISA as well as sandwich ELISA methods with the sensitivity of the
I-PCR method. Both ELISA methods were sensitive for toxin detection down to 50 fg, and
the I-PCR method was between 103 to 105 times more sensitive (Chao et al., 2004; Wu et
al., 2001). For more background on the basic principles of I-PCR, the reader is referred to
Niemeyer and colleagues (Niemeyer, Adler, and Wacker, 2005). The use of I-PCR for
highly sensitive detection of BoNT in food matrices or other biological backgrounds has
yet to be developed.
4.4 Activity based assays for detecting food contamination
Rapidly distinguishing between the presence and absence of active versus inactive toxin is
critical for intervention. Since BoNTs are zinc metalloproteases, enzyme-substrate assays
have been developed using knowledge of the human targets for these enzymes. Activity
assays range from mixing toxin with recombinant versions of host targets (such as SNAP-25)
and then using immunoblotting to detect cleavage of those substrates, to measuring
fluorescence emitted from cleavage of fluorogenic peptide substrates. One such peptide,
called SNAPtide, used in an assay with a reverse phase HPLC with a fluorescence detector,
can detect as low as 5 pg/mL of BoNT/A in skim milk (Christian, Suryadi, and Shine, 2010).
Other peptide substrates: VAMPtide and SYNTAXtide, useful for their cognate BoNTs have
been developed. The levels of substrate cleavage correlate well with toxin activity.
Other investigators have looked for other indications of substrate cleavage by BoNTs. For
instance, Nuss and colleagues generated antibodies that specifically recognize the fulllength version of human SNAP25 and not the cleaved form (Nuss et al, 2010). Use of this
antibody to confirm the absence of toxin activity (by detecting only the intact, full length
substrate) might be useful to confirm the absence of bioactive forms of the toxin.
Other activity-based approaches have used physical methods such as surface plasmon
resonance to detect cleavage of substrates. For instance, Ferraci and colleagues have
demonstrated that cleavage of the BoNT/B substrate VAMP2, a membrane SNARE protein
associated with synaptic vesicles, can be measured using real-time surface plasmon
resonance; vesicle capture is detected by specific antibodies coupled to microchips (Ferracci
et al., 2010). This assay is functional in low ionic strength buffers and stable over a wide
range of pH values (5.5-9.0). Cleavage of VAMP2 was detected within 10 minutes with 2 pM
of native BoNT/B holotoxin. Contamination of liquid food products such as carrot juice,
apple juice, and milk with low picomolar amounts of BoNT/B toxin is revealed within 3
hours. BoNT/B activity was detected in sera samples from botulism patients but not in
healthy patients or in patients with other neurological diseases.
4.4.1 Cell-based assays and their possible use in detecting food contamination
Cell-based assays measure BoNT receptor biding, translocation and enzymatic activity and
can be viable alternatives to the mouse bioassay. A number of different neuronal and nonneuronal derived cell lines have been generated for use in BoNT assays. These include: rat
spinal cord cells (Pellett et al., 2007); chick embryo neuronal cells (Stahl et al., 2007);
neuroblastoma cells N2A (Eubanks et al., 2007); and BE(2)-M17 cells (Hale et al., 2011). The
read-out for most of the cell-based assays for detection of BoNT/A is the cleavage of SNAP25. Antibodies for SNAP-25 allow immunoblot detection of cleavage products, specifically
detecting a decrease in size of endogenous SNAP-25 protein.
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Investigators continue to examine different parameters in order to develop a more robust
cell-based assay. The U.S. Food and Drug Administration recently approved a cell-based
assay developed by Allergan for use as possible replacement of the mouse bioassay. Details
of the assay have yet to be published. Cell -based assays may yet prove valuable for toxin
detection in food.
4.5 Combining assay methods to increase detection sensitivity
Detection methods can exploit the power of sensitive antibodies for enrichment or sample
preparation, as well as the signal amplification ability of enzymatic assays. Two recent
approaches are highlighted below.
4.5.1 ALISSA (assay with a large immunosorbent surface area)
The ALISSA utilizes a two-step approach; first, an antibody-mediated step concentrates
toxin onto a large bead surface. Captured toxin molecules are then subjected to a SNAPtide
protease assay (Bagramyan et al., 2008). When compared to other established methods for
toxin detection in food matrices, the ALISSA assay can detect toxin concentrations as low as
50 fg/mL, more sensitive than the mouse bioassay or either immunoassay or SNAPtide
assay alone. The use of this method to evaluate a number of different food matrices suggests
that it may be useful in food contamination studies.
4.5.2 ENDOPEP-MS: antibodies, activity assays, and mass spectrometry
The ENDOPEP-MS method uses antibodies to concentrate and extract BoNT serotypes A, B,
E, and F from test samples. The concentrated toxins are then subjected to an endopeptidase
activity-based assay to generate target cleavage products. Finally, mass spectrometry is used
to identify cleavage target products (Kalb et al., 2005; Kalb et al., 2006). This approach has
been successful in identifying BoNT serotypes A, B, E, and F in a variety of food and clinical
sample matrices with sub-mouse bioassay sensitivities. To advance this technique even
further, a single, high-affinity mAb (4E17.1) that can simultaneous identify BoNT serotypes
A, B, E and F has been developed (Kalb et al., 2010). The use of this mAb reduced assay time
while maintaining assay sensitivity. The use of mass spectrometry can give fast and
definitive results. With the future development of low cost equipment, this method may be
more readily available to investigators.

5. Conclusion
Detection of BoNT presents a unique set of challenges. The high toxicity of BoNT requires
detection methods capable of toxin measurement in the low to sub pg/mL range. PCR
methods can readily detect the presence of low levels of C. botulinum DNA but do not detect
the presence or absence of the toxin. In many cases, such as blood samples, only toxin may
be present. Current methods for toxin detection rely on 1) the gold standard mouse
bioassay, or 2) in vitro tests such as molecular tests, immunoassays and/or activity-based
assays. Recent improvements in the generation of high-affinity mAbs have resulted in
immunoassays with sensitivities equal to or lower than the mouse bioassay. However these
tests generally do not distinguish active from inactive toxin. Activity-based assays can detect
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active toxin but generally have poorer detection limits than immunoassays. New assays
must also be carefully validated in individual food matrices or for as many toxin subtypes as
possible, in order to establish assay performance standards. With refinement of the methods
described above, the prospect of an assay that is sensitive, cost effective, and fast could be
possible for use in food or other biological samples. Furthermore, these new strategies for
assay development can easily be extended to other toxins and pathogens.
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